Ignite Creation Date:
2024-05-06 @ 6:28 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05675462
Status:
RECRUITING
Last Update Posted:
2023-03-06
First Post:
2022-12-29
Brief Title:
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
Sponsor:
Fudan University
Organization:
Fudan University
Organization Data
Organization:
Fudan University
Class:
OTHER
Study ID:
OPTIONS-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fudan University
Lead Sponsor Class:
OTHER
Responsible Party:
Peng Wang
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fudan University
Old Name:
None
Old Organization:
None